SKU: DHC226 | Published On: Jan 27 2021 | No. of Pages: 180 | Available Formats
The Global Immuno Oncology Assays Market is expected to grow at a CAGR of 12.19% during the forecasting period (2020-2027).
Research methodology
Market Snippet by Condition
Market Snippet by Product type
Market Snippet by Technology
Market Snippet by Application
Market Snippet by Assay type
Market Snippet by Indication
Market Impacting Factors
Drivers
The increasing adoption of targeted therapy over traditional therapy
The increasing demand for mAbs
The rise in the incidence of cancer
Technological advancements in molecular techniques
Extensive research and development in cancer diagnostics
Restraints
The high cost of immunotherapy treatment
The high attrition rate in the product development cycle
Impact Analysis
Porter's Five Forces Analysis
Supply Chain Analysis
Regulatory Analysis
Pricing Analysis
Technology Advances
Key Companies to Watch
Epidemiology
Global Immuno oncology assays Market – By Product type
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
Market Attractiveness Index, By Product type
Consumables *
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%)
Software
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), Technology
Market Attractiveness Index, Technology
Immunoassay *
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
PCR
NGS
Flow Cytometry
Other
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), Application
Market Attractiveness Index, Application
Clinical Diagnostics *
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
Research
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), Assay type
Market Attractiveness Index, Assay type
Cell proliferation assays *
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
Cell migration & invasion assays
Phagocytosis assays
Immune cell killing assays,
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), Indication
Market Attractiveness Index, Indication
Colorectal Cancer *
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), 2018-2026
Lung Cancer
Melanoma
Bladder Cancer
Others
Introduction
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
Market Attractiveness Index, By Region
North America
Introduction
Key Region-Specific Dynamics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
The U.S.
Canada
Mexico
Europe
Introduction
Key Region-Specific Dynamics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay type
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
Germany
The U.K.
France
Italy
Spain
Rest of Europe
South America
Introduction
Key Region-Specific Dynamics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay type
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
Brazil
Argentina
Rest of South America
Asia-Pacific
Introduction
Key Region-Specific Dynamics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay type
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
China
India
Japan
Australia
Rest of Asia Pacific
The Middle East and Africa
Introduction
Key Region-Specific Dynamics
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Assay type
Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
Competitive Scenario
Competitor Tendinitis Treatment Strategy Analysis
Comparative Product Portfolio Analysis
Market Positioning/Share Analysis
Mergers and Acquisitions Analysis
Appendix
About Us and Services
Contact Us
Table 1 Global Immuno oncology assays Market Value, By Products & Equipment, 2018,2022 & 2027 ($ Million)
Table 2 Global Immuno oncology assays Market Value, By Technology, 2018,2022 & 2027 ($ Million)
Table 3 Global Immuno oncology assays Market Value, By Application, 2018,2022 & 2027 ($ Million)
Table 4 Global Immuno oncology assays Market Value, By Assay type, 2018,2022 & 2027 ($ Million)
Table 5 Global Immuno oncology assays Market Value, By Indication, 2018,2022 & 2027 ($ Million)
Table 6 Global Immuno oncology assays Market Value, By Region, 2018,2022 & 2027 ($ Million)
Table 7 Global Immuno oncology assays Market Value, By Products & Equipment, 2018,2022 & 2027 ($ Million)
Table 8 Global Immuno oncology assays Market Value, By Products & Equipment, 2017-2027 ($ Million)
Table 9 Global Immuno oncology assays Market Value, By Technology, 2018,2022 & 2027 ($ Million)
Table 10 Global Immuno oncology assays Market Value, By Technology, 2017-2027 ($ Million)
Table 11 Global Immuno oncology assays Market Value, By Application, 2018,2022 & 2027 ($ Million)
Table 12 Global Immuno oncology assays Market Value, By Application, 2017-2027 ($ Million)
Table 13 Global Immuno oncology assays Market Value, By Assay type, 2018,2022 & 2027 ($ Million)
Table 14 Global Immuno oncology assays Market Value, By Assay type, 2017-2027 ($ Million)
Table 15 Global Immuno oncology assays Market Value, By Indication, 2018,2022 & 2027 ($ Million)
Table 16 Global Immuno oncology assays Market Value, By Indication, 2017-2027 ($ Million)
Table 17 Global Immuno oncology assays Market Value, By Region, 2018,2022 & 2027 ($ Million)
Table 18 Global Immuno oncology assays Market Value, By Region, 2017-2027 ($ Million)
Table 19 North America Immuno oncology assays Market Value, By Products & Equipment, 2017-2027 ($ Million)
Table 20 North America Immuno oncology assays Market Value, By Technology, 2017-2027 ($ Million)
Table 21 North America Immuno oncology assays Market Value, By Application, 2017-2027 ($ Million)
Table 22 North America Immuno oncology assays Market Value, By Assay type, 2017-2027 ($ Million)
Table 23 North America Immuno oncology assays Market Value, By Indication, 2017-2027 ($ Million)
Table 24 North America Immuno oncology assays Market Value, By Country, 2017-2027 ($ Million)
Table 25 South America Immuno oncology assays Market Value, By Products & Equipment, 2017-2027 ($ Million)
Table 26 South America Immuno oncology assays Market Value, By Technology, 2017-2027 ($ Million)
Table 27 South America Immuno oncology assays Market Value, By Application, 2017-2027 ($ Million)
Table 28 South America Immuno oncology assays Market Value, By Assay type, 2017-2027 ($ Million)
Table 29 South America Immuno oncology assays Market Value, By Indication, 2017-2027 ($ Million)
Table 30 South America Immuno oncology assays Market Value, By Country, 2017-2027 ($ Million)
Table 31 Europe Immuno oncology assays Market Value, By Products & Equipment, 2017-2027 ($ Million)
Table 32 Europe Immuno oncology assays Market Value, By Technology, 2017-2027 ($ Million)
Table 33 Europe Immuno oncology assays Market Value, By Application, 2017-2027 ($ Million)
Table 34 Europe Immuno oncology assays Market Value, By Assay type, 2017-2027 ($ Million)
Table 35 Europe Immuno oncology assays Market Value, By Indication, 2017-2027 ($ Million)
Table 36 Europe Immuno oncology assays Market Value, By Country, 2017-2027 ($ Million)
Table 37 Asia-Pacific Immuno oncology assays Market Value, By Products & Equipment, 2017-2027 ($ Million)
Table 38 Asia-Pacific Immuno oncology assays Market Value, By Technology, 2017-2027 ($ Million)
Table 39 Asia-Pacific Immuno oncology assays Market Value, By Application, 2017-2027 ($ Million)
Table 40 Asia-Pacific Immuno oncology assays Market Value, By Assay type, 2017-2027 ($ Million)
Table 41 Asia-Pacific Immuno oncology assays Market Value, By Indication, 2017-2027 ($ Million)
Table 42 Asia-Pacific Immuno oncology assays Market Value, By Country, 2017-2027 ($ Million)
Table 43 Middle East & Africa Immuno oncology assays Market Value, By Products & Equipment, 2017-2027 ($ Million)
Table 44 Middle East & Africa Immuno oncology assays Market Value, By Technology, 2017-2027 ($ Million)
Table 45 Middle East & Africa Immuno oncology assays Market Value, By Application, 2017-2027 ($ Million)
Table 46 Middle East & Africa Immuno oncology assays Market Value, By Assay type, 2017-2027 ($ Million)
Table 47 Middle East & Africa Immuno oncology assays Market Value, By Indication, 2017-2027 ($ Million)
Table 48 Agilent Technologies, Inc: Overview
Table 49 Agilent Technologies, Inc: Product Portfolio
Table 50 Agilent Technologies, Inc: Key Developments
Table 51 F. Hoffmann-La Roche Ltd: Overview
Table 52 F. Hoffmann-La Roche Ltd: Product Portfolio
Table 53 F. Hoffmann-La Roche Ltd: Key Developments
Table 54 Foundation Medicine, Inc.: Overview
Table 55 Foundation Medicine, Inc.: Product Portfolio
Table 56 Foundation Medicine, Inc.: Key Developments
Table 57 HTG Molecular Diagnostics, Inc.: Overview
Table 58 HTG Molecular Diagnostics, Inc.: Product Portfolio
Table 59 HTG Molecular Diagnostics, Inc.: Key Developments
Table 60 Illumina, Inc.: Overview
Table 61 Illumina, Inc.: Product Portfolio
Table 62 Illumina, Inc.: Key Developments
Table 63 Merck KGaA: Overview
Table 64 Merck KGaA: Product Portfolio
Table 65 Merck KGaA: Key Developments
Table 66 NanoString Technologies, Inc.: Overview
Table 67 NanoString Technologies, Inc.: Product Portfolio
Table 68 NanoString Technologies, Inc.: Key Developments
Table 69 PerkinElmer Inc.: Overview
Table 70 PerkinElmer Inc.: Product Portfolio
Table 71 PerkinElmer Inc.: Key Developments
Table 72 Qiagen: Overview
Table 73 Qiagen: Product Portfolio
Table 74 Qiagen: Key Developments
Table 75 Sartorius AG: Overview
Table 76 Sartorius AG: Product Portfolio
Table 77 Sartorius AG: Key Developments
List of Figures
Figure 1 Global Immuno oncology assays Market Share, By Products & Equipment, 2018 & 2027 (%)
Figure 2 Global Immuno oncology assays Market Share, By Technology, 2018 & 2027 (%)
Figure 3 Global Immuno oncology assays Market Share, By Application, 2018 & 2027 (%)
Figure 4 Global Immuno oncology assays Market Share, By Assay type, 2018 & 2027 (%)
Figure 5 Global Immuno oncology assays Market Share, By Indication, 2018 & 2027 (%)
Figure 6 Global Immuno oncology assays Market Share, By Region, 2018 & 2027 (%)
Figure 7 Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 8 Global Immuno oncology assays Market Y-o-Y Growth, By Products & Equipment, 2018-2027 (%)
Figure 9 Consumables: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 10 Software: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 11 Global Immuno oncology assays Market Y-o-Y Growth, By Technology, 2018-2027 (%)
Figure 12 Immunoassay: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 13 PCR: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 14 NGS: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 15 Flow Cytometry: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 16 Others: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 17 Global Immuno oncology assays Market Y-o-Y Growth, By Application, 2018-2027 (%)
Figure 18 Clinical Diagnostics: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 19 Laparoscopic Surgery: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 20 Open tension repair: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 21 Global Immuno oncology assays Market Y-o-Y Growth, By Assay type, 2018-2027 (%)
Figure 22 cell proliferation assays: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 23 cell migration & invasion assays: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 24 phagocytosis assays: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 25 immune cell killing assays: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 26 Others: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 27 Global Immuno oncology assays Market Y-o-Y Growth, By Indication, 2018-2027 (%)
Figure 28 Colorectal Cancer: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 29 Lung Cancer: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 30 Melanoma: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 31 Bladder Cancer: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 32 Others: Global Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 33 Global Immuno oncology assays Market Y-o-Y Growth, By Region, 2018-2027 (%)
Figure 34 North America Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 35 North America Immuno oncology assays Market Share, By Products & Equipment, 2018 & 2027 (%)
Figure 36 North America Immuno oncology assays Market Share, By Technology, 2018 & 2027 (%)
Figure 37 North America Immuno oncology assays Market Share, By Application, 2018 & 2027 (%)
Figure 38 North America Immuno oncology assays Market Share, By Assay type, 2018 & 2027 (%)
Figure 39 North America Immuno oncology assays Market Share, By Indication, 2018 & 2027 (%)
Figure 40 North America Immuno oncology assays Market Share, By Country, 2018 & 2027 (%)
Figure 41 South America Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 42 South America Immuno oncology assays Market Share, By Products & Equipment, 2018 & 2027 (%)
Figure 43 South America Immuno oncology assays Market Share, By Technology, 2018 & 2027 (%)
Figure 44 South America Immuno oncology assays Market Share, By Application, 2018 & 2027 (%)
Figure 45 South America Immuno oncology assays Market Share, By Assay type, 2018 & 2027 (%)
Figure 46 South America Immuno oncology assays Market Share, By Indication, 2018 & 2027 (%)
Figure 47 South America Immuno oncology assays Market Share, By Country, 2018 & 2027 (%)
Figure 48 Europe Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 49 Europe Immuno oncology assays Market Share, By Products & Equipment, 2018 & 2027 (%)
Figure 50 Europe Immuno oncology assays Market Share, By Technology, 2018 & 2027 (%)
Figure 51 Europe Immuno oncology assays Market Share, By Application, 2018 & 2027 (%)
Figure 52 Europe Immuno oncology assays Market Share, By Assay type, 2018 & 2027 (%)
Figure 53 Europe Immuno oncology assays Market Share, By Indication, 2018 & 2027 (%)
Figure 54 Europe Immuno oncology assays Market Share, By Country, 2018 & 2027 (%)
Figure 55 Asia-Pacific Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 56 Asia-Pacific Immuno oncology assays Market Share, By Products & Equipment, 2018 & 2027 (%)
Figure 57 Asia-Pacific Immuno oncology assays Market Share, By Technology, 2018 & 2027 (%)
Figure 58 Asia-Pacific Immuno oncology assays Market Share, By Application, 2018 & 2027 (%)
Figure 59 Asia-Pacific Immuno oncology assays Market Share, By Assay type, 2018 & 2027 (%)
Figure 60 Asia-Pacific Immuno oncology assays Market Share, By Indication, 2018 & 2027 (%)
Figure 61 Asia-Pacific Immuno oncology assays Market Share, By Country, 2018 & 2027 (%)
Figure 62 Middle East & Africa Immuno oncology assays Market Value, 2017-2027 ($ Million)
Figure 63 the Middle East & Africa Immuno oncology assays Market Share, By Products & Equipment, 2018 & 2027 (%)
Figure 64 the Middle East & Africa Immuno oncology assays Market Share, By Technology, 2018 & 2027 (%)
Figure 65 the Middle East & Africa Immuno oncology assays Market Share, By Application, 2018 & 2027 (%)
Figure 66 the Middle East & Africa Immuno oncology assays Market Share, By Assay type, 2018 & 2027 (%)
Figure 67 the Middle East & Africa Immuno oncology assays Market Share, By Indication, 2018 & 2027 (%)
Figure 68 Agilent Technologies, Inc: Financials
Figure 69 F. Hoffmann-La Roche Ltd: Financials
Figure 70 Foundation Medicine, Inc.: Financials
Figure 71 HTG Molecular Diagnostics, Inc.: Financials
Figure 72 Illumina, Inc.: Financials
Figure 73 Merck KGaA: Financials
Figure 74 NanoString Technologies, Inc.: Financials
Figure 75 PerkinElmer Inc.: Financials
Figure 76 Qiagen: Financials
Figure 77 Sartorius AG: Financials
Get your FREE SAMPLE PROPOSAL with a single click!